Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
Norway

PMID:28928238  

TALK-1 channels control β cell endoplasmic reticulum Ca2+ homeostasis.

Nicholas C Vierra | Prasanna K Dadi | Sarah C Milian | Matthew T Dickerson | Kelli L Jordan | Patrick Gilon | David A Jacobson
Science signaling | 2017

Ca2+ handling by the endoplasmic reticulum (ER) serves critical roles in controlling pancreatic β cell function and becomes perturbed during the pathogenesis of diabetes. ER Ca2+ homeostasis is determined by ion movements across the ER membrane, including K+ flux through K+ channels. We demonstrated that K+ flux through ER-localized TALK-1 channels facilitated Ca2+ release from the ER in mouse and human β cells. We found that β cells from mice lacking TALK-1 exhibited reduced basal cytosolic Ca2+ and increased ER Ca2+ concentrations, suggesting reduced ER Ca2+ leak. These changes in Ca2+ homeostasis were presumably due to TALK-1-mediated ER K+ flux, because we recorded K+ currents mediated by functional TALK-1 channels on the nuclear membrane, which is continuous with the ER. Moreover, overexpression of K+-impermeable TALK-1 channels in HEK293 cells did not reduce ER Ca2+ stores. Reduced ER Ca2+ content in β cells is associated with ER stress and islet dysfunction in diabetes, and islets from TALK-1-deficient mice fed a high-fat diet showed reduced signs of ER stress, suggesting that TALK-1 activity exacerbated ER stress. Our data establish TALK-1 channels as key regulators of β cell ER Ca2+ and suggest that TALK-1 may be a therapeutic target to reduce ER Ca2+ handling defects in β cells during the pathogenesis of diabetes.

Pubmed ID: 28928238

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK097392
  • Agency: NIDDK NIH HHS, United States
    Id: F31 DK109625
  • Agency: NIGMS NIH HHS, United States
    Id: R25 GM062459
  • Agency: NIDDK NIH HHS, United States
    Id: T32 DK101003
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK020593
  • Agency: NIDDK NIH HHS, United States
    Id: T32 DK007563
  • Agency: NIH HHS, United States
    Id: S10 OD021630
  • Agency: NIDDK NIH HHS, United States
    Id: U2C DK059637
  • Agency: NIDDK NIH HHS, United States
    Id: U24 DK059637
  • Agency: NIDDK NIH HHS, United States
    Id: K01 DK081666

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


National Mouse Metabolic Phenotyping Centers (tool)

RRID:SCR_008997

The mission is to advance medical and biological research by providing the scientific community with standardized, high quality metabolic and physiologic phenotyping services for mouse models of diabetes, diabetic complications, obesity and related disorders.

View all literature mentions